197 related articles for article (PubMed ID: 9152297)
21. Pamidronate treatment of hypercalcemia caused by vitamin D toxicity.
Chatterjee M; Speiser PW
J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1241-8. PubMed ID: 18183797
[TBL] [Abstract][Full Text] [Related]
22. Salmon calcitonin in the acute management of hypercalcemia.
Wisneski LA
Calcif Tissue Int; 1990; 46 Suppl():S26-30. PubMed ID: 2137363
[TBL] [Abstract][Full Text] [Related]
23. Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism.
Tal A; Graves L
South Med J; 1996 Jun; 89(6):637-40. PubMed ID: 8638211
[TBL] [Abstract][Full Text] [Related]
24. Electrolyte disturbances and cardiac arrhythmias in a dog following pamidronate, calcitonin, and furosemide administration for hypercalcemia of malignancy.
Kadar E; Rush JE; Wetmore L; Chan DL
J Am Anim Hosp Assoc; 2004; 40(1):75-81. PubMed ID: 14736909
[TBL] [Abstract][Full Text] [Related]
25. Update on the medical treatment of hypercalcemia of malignancy.
Hall TG; Schaiff RA
Clin Pharm; 1993 Feb; 12(2):117-25. PubMed ID: 8453860
[TBL] [Abstract][Full Text] [Related]
26. Treatment of hypercalcaemia of malignancy.
Heath DA
Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):139-45. PubMed ID: 2143893
[TBL] [Abstract][Full Text] [Related]
27. Hypercalcaemia in osteogenesis imperfecta treated with pamidronate.
Williams CJ; Smith RA; Ball RJ; Wilkinson H
Arch Dis Child; 1997 Feb; 76(2):169-70. PubMed ID: 9068314
[TBL] [Abstract][Full Text] [Related]
28. Severe hypercalcemia associated with Williams syndrome successfully treated with pamidronate infusion therapy.
Sangun O; Dundar BN; Erdogan E
J Pediatr Endocrinol Metab; 2011; 24(1-2):69-70. PubMed ID: 21528818
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of hypercalcemia of malignancy with pamidronate in a patient with advanced recurrent oral cancer].
Nishimura N; Matsushita Y; Takaoka K; Hashitani S; Noguchi K; Urade M
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2537-9. PubMed ID: 12506478
[TBL] [Abstract][Full Text] [Related]
30. Pamidronate (Aredia, Ciba) in malignant hypercalcaemia.
MacConnachie AM
Intensive Crit Care Nurs; 1997 Feb; 13(1):58-9. PubMed ID: 9095884
[TBL] [Abstract][Full Text] [Related]
31. The management of malignant hypercalcaemia.
Watters J; Gerrand G; Dodwell D
Drugs; 1996 Dec; 52(6):837-48. PubMed ID: 8957154
[TBL] [Abstract][Full Text] [Related]
32. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
McMahan J; Linneman T
Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
[TBL] [Abstract][Full Text] [Related]
33. Pamidronate-induced irreversible symptomatic hypocalcemia in a dog with hypercalcemia after glucocorticoid withdrawal: a case report.
Oh YI; An JH; Lim GH; Park SM; Kim TH; Seo KW; Youn HY
BMC Vet Res; 2024 May; 20(1):227. PubMed ID: 38790012
[TBL] [Abstract][Full Text] [Related]
34. The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication.
Lee DC; Lee GY
J Toxicol Clin Toxicol; 1998; 36(7):719-21. PubMed ID: 9865241
[TBL] [Abstract][Full Text] [Related]
35. Hypercalcemia of malignancy.
Body JJ
Semin Nephrol; 2004 Jan; 24(1):48-54. PubMed ID: 14730509
[TBL] [Abstract][Full Text] [Related]
36. The use of pamidronate in three children with renal disease.
Sellers E; Sharma A; Rodd C
Pediatr Nephrol; 1998 Nov; 12(9):778-81. PubMed ID: 9874327
[TBL] [Abstract][Full Text] [Related]
37. [Pamidronate in the treatment of tumor-associated hypercalcemia].
Pecherstorfer M; Janisch S; Marosi C; Wogritsch C; Bosse C; Schratzberger W; Gerber E; Fortelny A; Lenzhofer R; Rainer H
Klin Wochenschr; 1991 Oct; 69(15):690-5. PubMed ID: 1795492
[TBL] [Abstract][Full Text] [Related]
38. Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.
Ralston SH; Alzaid AA; Gardner MD; Boyle IT
Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1549-50. PubMed ID: 3087513
[TBL] [Abstract][Full Text] [Related]
39. Parathyroid hormone-related protein(50-69) and response to pamidronate therapy for tumour-induced hypercalcaemia.
Dodwell DJ; Abbas SK; Morton AR; Howell A
Eur J Cancer; 1991; 27(12):1629-33. PubMed ID: 1782072
[TBL] [Abstract][Full Text] [Related]
40. Fast and effective treatment of malignant hypercalcemia. Combination of suppositories of calcitonin and a single infusion of 3-amino 1-hydroxypropylidene-1-bisphosphonate.
Thiébaud D; Jacquet AF; Burckhardt P
Arch Intern Med; 1990 Oct; 150(10):2125-8. PubMed ID: 2222097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
